Publicaciones en colaboración con investigadores/as de Utrecht University (10)

2022

  1. Src kinase as a potential therapeutic target in non-alcoholic and alcoholic steatohepatitis

    Clinical and Translational Discovery, Vol. 2, Núm. 1

  2. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. Generation and characterization of novel co-stimulatory anti-mouse TNFR2 antibodies

    Journal of Immunological Methods, Vol. 499

2020

  1. Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma

    Hepatology Communications, Vol. 4, Núm. 6, pp. 834-851

2019

  1. Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)

    Nature Immunology

  2. ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development

    Nature Immunology

2018

  1. Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis

    Journal of Controlled Release, Vol. 288, pp. 227-238

2017

  1. Principles of mucin structure: Implications for the rational design of cancer vaccines derived from MUC1-glycopeptides

    Chemical Society Reviews, Vol. 46, Núm. 23, pp. 7154-7175

  2. The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer

    Journal of the American Chemical Society, Vol. 139, Núm. 50, pp. 18255-18261

1991

  1. Residues involved in the antigenic sites of transmissible gastroenteritis coronavirus S glycoprotein

    Virology, Vol. 183, Núm. 1, pp. 225-238